eyeforpharma Philadelphia 2017: Be the trusted healthcare partner #efpPhilly

eyeforpharma20 - 21 April 2017, Philadelphia, USA.
The democratization of healthcare is real, the healthcare delivery landscape is consolidating fast, and the patient is empowered and the customer in charge. Pharma needs to change and develop along with it.

One eyeforpharma Philadelphia. 6 in-depth commercial pharma conferences on the key issues of 2017 and beyond.

The 6 sessions will focus on:

  • Commercial Leadership
    The rules of the game have changed: we have moved away from a volume approach. We must recognize that our medicine is not the asset, it is merely one of our assets - another key asset being the understanding we have of our patient's lives. Our metrics have already moved away from sales, towards engagement. Find out how pharma's c-suite are embracing the new customer engagement paradigm.
  • The Heart of Customer Experience
    Make no mistake, it's 2017 and your customers are in charge. A positive, reliable experience at any touch point will be necessary to unleash new levels of engagement, loyalty and the rewards this brings for patients as well as your business. Help your customers succeed as a partner and differentiate your company through the way you engage.
  • Commercial Model Innovation
    Your face-to-face push model has evolved in the face of healthcare consumerization and provider consolidation. It's more vital than ever to develop an effective and sustainable commercial model. Understand the market dynamics and position your teams for industry leadership.
  • Digital Transformation & Technology
    As consumers, digital is key to everything we do. To ensure that your company is leveraging the technology transformation, you must ensure that digital is integral to your business plan. Join leaders in tech and industry and develop a strategic vision to embed digital throughout the organization.
  • Pharma's 'Triple Aim': Access, affordability and adherence
    New strategies are needed to help patients manage healthcare payment concerns and adherence through better assistance and engagement services than ever before. Hear action-driven case studies about the power of empathy in guiding successful patient support.
  • Patients as partners: Co-creation and shared decision-making
    Moving from 'words to action' has been a key imperative for those who want to lead patient-centric change in our industry. Looking at both partnerships with stakeholders and initiatives from within, our sessions will help you achieve 'quick-wins' as well as big transformations. See the full agenda here.

Why you can't miss The eyeforpharma Philadelphia Summit 2017

With 15 years of experience, eyeforpharma has tailored this summit to go beyond the offerings of a normal conference. The 2017 Summit will guarantee:
  • More Than 50 Executive-level Thought Leaders sharing their experience and knowledge. Take this opportunity to transform your organisation, become truly customer-centric and improve healthcare outcomes.
  • NO Sales Pitch: this is an independently researched event committed to equipping you with the techniques and expertise to drive your business. You will take-away actionable insights proven to drive your commercial strategy.
  • 10+ Hours of Dedicated Networking: Identify new business opportunities and develop valuable and lasting relationships with senior-level executives that create partnerships and collaborations beyond what's possible in the office.
  • NEW for 2017 - Innovative Sessions that Deepen Your Thinking: From Think Tanks, to Panel Debates, to Roundtables to Fire-side Chats, we can guarantee you a variety of sessions that will help you identify the answers to common challenges commercial professionals are faced with.
  • Included in your Philly pass: eyeforpharma Philadelphia has just gotten bigger, one-pass will not gain you access to eyeforpharma's "Brand New" Medical Affairs meeting

Join the most forward thinking speakers from across North America including C-level, VPs and industry leaders from Shire, Otsuka, GSK, Novartis, Pfizer, Google, Sanofi, Takeda and many more. This is the ideal place to ensure your commercial strategy is prepared for 2017 and beyond.

World Pharma News readers can benefit from an exclusive discount - save $200 using our unique discount code WPN200 when you register online.

For further information, please visit:
http://www.eyeforpharma.com/philadelphia/

About eyeforpharma
Our mission is to make pharma more open and valued. The ultimate driver for the pharmaceutical industry's health is meeting the needs of patients, otherwise it will cease to matter. For healthcare to be as good as it could be, the strength, skills and resources of our industry need to be fully integrated into health outcomes and we need pharma experience at the decision-making table. We believe the industry must focus on a business model combining service with product, with patients at the center.

Most Popular Now

A need for bananas? Dietary potassium regulates ca…

Bananas and avocados - foods that are rich in potassium - may help protect against pathogenic vascular calcification, also known as hardening of the arteries. University ...

FDA awards 15 grants for clinical trials to stimul…

The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to...

Amgen and CytomX Therapeutics announce strategic c…

Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. The co...

Novartis and The Max Foundation transform pioneeri…

Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid...

Roche launches NAVIFY Tumor Board solution to prov…

Roche (SIX: RO, ROG; OTCQX:RHHBY), has announced the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-...

AbbVie and Bristol-Myers Squibb announce clinical …

AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial collaboration to evaluate the combination of AbbVie's investigational an...

Tagrisso granted breakthrough therapy designation …

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatm...

Pfizer launches novel programs to put important su…

Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer...

Novartis and UC Berkeley collaborate to tackle 'un…

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pu...

Printed meds could reinvent pharmacies, drug resea…

A technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharma...

Danish discovery can pave the way for more effecti…

More than 600,000 Danes are being treated with cholesterol lowering medicine. 98 per cent of them are treated with statins, which curb the body's own production of choles...

Amgen and Simcere announce strategic collaboration…

Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. Th...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]